News

Patients with chronic kidney disease and diabetes saw lower rates of heart rhythm disorder, other benefits

Ultromics’ cloud-based, AI platform was tapped to speedily review data from 13 medical centers in nine countries

Study is first to track objective, real-time alcohol consumption and heart rhythm disturbance

Multi-institutional team combined expertise to make discovery

Researchers recommend procedure as surgery add-on for patients with atrial fibrillation

Oral anticoagulation reduces clot formation around the implanted valve with no increased bleeding risk

WATCHMAN device shows favorable safety profile even in older, higher-risk patient population

Study sheds light on urgent need to improve health care work environments

Milestone Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, announced the presentation of data related to key secondary endpoints from its Phase 3,...

Mavacamten, a potential first-in-class cardiac myosin inhibitor for patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), showed improvement in health status compared to placebo at 30 weeks in EXPLORER-HCM trial Bristol...